Kraig Biocraft Laboratories secures bridge funding

Kraig Biocraft Laboratories Inc. has secured $950,000 in bridge financing and simultaneously filed with the SEC to become a mandatory, fully reporting company. The company recently filed a Form 8-A to become a fully reporting issuer.

“While being a voluntary filer, Kraig has been committed to meeting all SEC filing and reporting standards. Our election to now formalize these reporting responsibilities is evidence of our commitment to full operational transparency and growth,” says CEO and founder, Kim Thompson. “The bridge financing will be used to continue scaling up our recombinant spider silk production and for other purposes related to the near term implementation of our business plan.”